{
    "clinical_study": {
        "@rank": "141172", 
        "arm_group": [
            {
                "arm_group_label": "DMD infant", 
                "arm_group_type": "Other", 
                "description": "Muscle biopsy"
            }, 
            {
                "arm_group_label": "Control infant", 
                "arm_group_type": "Other", 
                "description": "Muscle biopsy (during lower limb operation surgery for pure orthopedic causes)"
            }
        ], 
        "brief_summary": {
            "textblock": "Duchenne muscular dystrophy (DMD) is the most common and devastating form of muscular\n      dystrophy, caused by an X-chromosome gene mutation resulting in the absence of the protein\n      dystrophin. Gene therapy by exon skipping or stop codon read-through and cell therapy are at\n      the stage of clinical assays with very promising results. Nevertheless, they will not allow\n      a complete cure of DMD patients and they will concern only specific types of mutations. It\n      is therefore crucial to develop other therapeutic strategies related to the natural history\n      of the disease and targeted not on the dystrophin itself, but on the consequences of its\n      absence.\n\n      Another crucial pathophysiological pathway in DMD is muscle cell calcium homeostasis,\n      particularly via the ryanodine recepteur (RyR1).\n\n      Our study focus on the relationship between endomysial fibrosis, abnormal inflammation\n      response and calcium homeostasis dysfunction which are not entirely established in DMD.\n\n      The identification of the biological mechanisms that play a role in the severity of the\n      phenotype, particularly endomysial fibrosis, should allow the development of targeted\n      pharmacotherapy as a complementary strategy for the future treatment of DMD."
        }, 
        "brief_title": "Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Duchenne Muscular Distrophy (DMD)", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophy, Duchenne", 
                "Fibrosis", 
                "Muscular Dystrophies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Boy between 2 to 15 years old.\n\n          -  Lack of any infectious disease in the last week before the study.\n\n          -  Consent form signed by parents.\n\n        Inclusion Criteria for DMD infant\n\n          -  Clinical suspicion of Duchenne Muscular Dystrophy\n\n        Inclusion Criteria for Control healthy Infant\n\n          -  Lack of any antecedent of congenital cardiac, pulmonary or muscular disease including\n             DMD.\n\n        Exclusion Criteria:\n\n          -  Subjects who are unable or unwilling to tolerate study constraints\n\n          -  Parents of the subject unable or unwilling to undergo informed consent\n\n          -  Subject with no rights from the national health insurance programme"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "15 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823783", 
            "org_study_id": "8948"
        }, 
        "intervention": {
            "arm_group_label": [
                "DMD infant", 
                "Control infant"
            ], 
            "description": "Muscle biopsy", 
            "intervention_name": "Muscle biopsy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Duchenne muscular distrophy", 
            "Endomysial Fibrosis", 
            "Muscular Inflammatory Response", 
            "Calcium Homeostasis Dysfunction", 
            "Muscle biopsy"
        ], 
        "lastchanged_date": "March 29, 2013", 
        "location": [
            {
                "contact": {
                    "email": "caroline.epsil@chu-bordeaux.fr", 
                    "last_name": "Caroline Epsil"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "UH Bordeaux"
                }, 
                "investigator": {
                    "last_name": "Caroline Epsil, PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jean-marie.cuisset@chru-lille.fr", 
                    "last_name": "Jean-Marie Cuisset, PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "UH Lille"
                }, 
                "investigator": {
                    "last_name": "Jean-Marie Cuisset, PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "c-chauveton@chu-montpellier.fr", 
                    "last_name": "Claire Chauveton"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Montpellier University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Fran\u00e7ois RIVIER, PU PH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Stefan Matecki, PU PH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Pierre Meyer, PH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ulrike Walther-Louvier, PH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "J\u00e9rome Cottalorda, PU PH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "isabelle.desguerre@nck.aphp.fr", 
                    "last_name": "Isabelle DESGUERRE, PU PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75743"
                    }, 
                    "name": "Necker Hospital"
                }, 
                "investigator": {
                    "last_name": "Isabelle Desguerre, PU PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "psabouraud@chu-reims.fr", 
                    "last_name": "Pascal Sabouraud, PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51092"
                    }, 
                    "name": "UH Reims"
                }, 
                "investigator": {
                    "last_name": "Pascal Sabouraud, PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "stephane.chabrier@chu-st-etienne.fr", 
                    "last_name": "St\u00e9phane CHABRIER, PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Etienne", 
                        "country": "France", 
                        "zip": "42055"
                    }, 
                    "name": "UH Saint Etienne"
                }, 
                "investigator": [
                    {
                        "last_name": "St\u00e9phane CHABRIER, PH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Leonard Feasson, PH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cances.c@chu-toulouse.fr", 
                    "last_name": "Claude Cances, PU PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "UH Toulouse"
                }, 
                "investigator": {
                    "last_name": "Claude Cances, PU PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction : Potential Links and Targeted Pharmacotherapy in Duchenne Muscular Dystrophy (DMD).", 
        "overall_contact": {
            "email": "f-rivier@chu-montpellier.fr", 
            "last_name": "Fran\u00e7ois RIVIER, PU PH"
        }, 
        "overall_contact_backup": {
            "email": "s-matecki@chu-montpellier.fr", 
            "last_name": "Stefan Matecki, PU PH"
        }, 
        "overall_official": {
            "affiliation": "uh montpellier", 
            "last_name": "Fran\u00e7ois RIVIER, PU PH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Quantification of endomysial fibrosis", 
                "safety_issue": "No", 
                "time_frame": "1 day (biopsy day)"
            }, 
            {
                "description": "Measure of the protein (Immunofluorescence and western blot) and mRNA (qRT-PCR) expression of the following markers of muscular inflammation response\nPresence and quantification of cellular partners of inflammation and muscle regeneration (M1 (CD68/KP1) and M2 (CD206) macrophages, quiescent and activated satellite cells (CD56/NCAM) and endothelial cells (CD31/PECAM-1)).", 
                "measure": "quantification of the muscle inflammation", 
                "safety_issue": "No", 
                "time_frame": "1 day (biopsy day)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823783"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}